MEBIS, Jeroen

Email Alert RSS Feed

Profile

Full Name
MEBIS, Jeroen
Email
jeroen.mebis@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 81-100 of 100 (Search time: 0.089 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
812015Low-level laser therapy as a tool for the management of radiodermatitis: a pilot study in breast cancer patientsROBIJNS, Jolien; CENSABELLA, S.; CLAES, S.; BULENS, Paul; MEBIS, JeroenConference MaterialC2
22015Thrombo-Embolic Events in Cancer Patients with Impaired Renal FunctionElalamy, I.; Canon, J.L.; Bols, A.; Lybaert, W.; Duck, L.; Jochmans, K.; Bosquée, L.; Peeters, M.; Awada, A.; Clement, P.; Holbrechts, S.; Baurain, J.F.; MEBIS, Jeroen; Nortier, J.Journal ContributionA1
32015Low level laser therapy for the management of radiation dermatitis: final results of the dermis trial, a pilot study in breast cancer patientsCensabella, S.; ROBIJNS, Jolien; Claes, S.; BULENS, Paul; MEBIS, JeroenProceedings PaperC1
642014Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapyBatair, A.; Van Fraeyenhoven, F.; Vandebroek, A.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D.Journal ContributionA1
652014Low level laser therapy for the management of radiation dermatitis: Preliminary results of a pilot study in breast cancer patientsCENSABELLA, S.; ROBIJNS, Jolien; CLAES, S.; BULENS, Paul; MEBIS, JeroenJournal ContributionM
662013‘Screening cancer patients distress and care needs: translation and validation of the Cancer Rehabilitation Evaluation System (CARES) for the Flemish population in Belgium.’SCHOUTEN, Bojoura; VAN HOOF, Elke; Vankrunkelsven, Patrick; BULENS, Paul; MEBIS, Jeroen; Vandenborre, Katherine; HELLINGS, JohanConference MaterialC2
672013Non-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case reportVan Ginderachter, Laura; Cox, Tony; Drijkoningen, Ria; ACHTEN, Ruth; Joosens, Eric; Maes, Annelies; Theunissen, Koen; MEBIS, JeroenJournal ContributionA2
682013Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancerBaitar, A.; van Fraeyenhove, F.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D.Journal ContributionA1
692012The 2006 Adjuvant Trastuzumab Convention in Belgium: 5 years laterVanderhaegen, J.; Paridaens, R.; Piccart, M.; Lalami, Y.; Machiels, J.P.; Jerusalem, G.; Borms, M.; Goemine, J.; MEBIS, Jeroen; Dirix, L.; Lintermans, A.; Brouckaert, O.; Neven, P.Conference MaterialC2
702012Adherence to oral anticancer drugs (OAD) in patients (pts) with metastatic renal cancer (mRCC): First results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral Anti-cancer Treatment).Wolter, Pascal; Hendrickx, Tine; Renard, Vincent; MEBIS, Jeroen; Debruyne, Philip R.; Wynendaele, Wim; Schallier, Denis C. C.; Vermeij, Joanna; Nielander, Aldrik; Machiels, Jean-Pascal H.; Rottey, Sylvie; Delande, Stephanie; Goeminne, Jean-Charles; Schoffski, Patrick; De Coster, Sandra; Lacour, Valerie; Foulon, VeerleJournal ContributionM
712012Will ‘fit’ older cancer patients as assessed by frailty screening tools tolerate the first cycle of (radio)chemotherapy without serious adverse events?MEBIS, JeroenConference MaterialC2
722012Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST TrialLlombart, Antonio; Frassoldati, Antonio; Paija, Outi; Sleeboom, Harm Peter; Jerusalem, Guy; MEBIS, Jeroen; Deleu, Ines; Miller, Joel; Schenk, Nora; Neven, PatrickJournal ContributionA1
732012Metabolic phenotype by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; REEKMANS, Gunter; BAETEN, Kurt; MESOTTEN, Liesbet; THOMEER, Michiel; VANHOVE, Karolien; MEBIS, Jeroen; Vandeurzen, Kurt; Darquennes, Karen; ADRIAENSENS, PeterConference MaterialC2
742012Metabolic phenotype by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, PeterConference MaterialC2
752011Metabolic phenotyping by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, PeterConference MaterialC2
762010Melanoma incidence trends in Limburg after screening and prevention campaignsVanstraelen, D.; Deleu, H.; VAN ROBAYS, Johan; DHollander, D.; CLOES, Edith; Lousberg, D.; Kuijpers, G.; ADRIAENS, Brecht; MEBIS, Jeroen; Mathei, Catharina; Buntinx, F.Journal ContributionA2
772010Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematological malignancy after antibiotic change: a single centre prospective study with 15 years of follow-upMEBIS, Jeroen; Jansens, Hilde; AYELE, Girma; MOLENBERGHS, Geert; Schroyens, W.; Gadisseur, Alain; Van de Velde, An L. R.; Vrelust, Inge; Goossens, Herman; Berneman, Zwi N.Journal ContributionA1
782007Invloed van een multidisciplinair revalidatieprogramma op de fysiek en psychosociale conditie van patiënten met een oncologische pathologieVAN HOOF, Elke; Charlier, C; Wijmans, M; MEBIS, Jeroen; CLAES, GuidoBookB3
792005Pseudo-thrombopenie. Een niet altijd even goed gekend laboartoriumfenomeen.De Greef, Y.; Claeys, R.; MEBIS, Jeroen; Janssen, M.; Vanstraelen, D.; Madoe, V.; RUMMENS, Jean-Luc; Bries, G.Journal ContributionA1
802005Oncologische revalidatie : een stap voorwaarts in een kwaliteitsvolle zorg van de kankerpatiëntDe Greef, Y.; DENDALE, Paul; CLAES, Guido; Vanstraelen, D.; Madoe, V.; Bries, G.; MAES, Annelies; Brosens, M.; BULENS, Paul; MEBIS, JeroenJournal ContributionA1
show all